Raising the awareness of hypoglycaemia amongst healthcare professionals to provide support for families

Scott, Adrian
December 2013
Diabetes Digest;2013, Vol. 12 Issue 4, p166
The article discusses the importance to raise the awareness of hypoglycaemia in healthcare professionals and consider the development of proactive support for families. The response of clinicians to people with high blood glucose of getting them down followed by results from the Diabetes Control and Complications Trials (DCCT) is mentioned. Results from a study of 24 adult family members of people having type 1 diabetes (T1D) to examine the effect of hypoglycaemia unawareness (HU) is provided.


Related Articles

  • Hypoglycaemia. Sen Gupta, Piya; Green, Andrea N.; Chowdhury, Tahseen A. // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;2/19/2011, Vol. 342 Issue 7794, p438 

    The article discusses the medical case of a 58-year-old white man who has had type 2 diabetes for almost a decade. The patient experiences frequent hypoglycaemic episodes and regularly takes a daily dose of basal insulin glargine. The article explains that hypoglycaemia in diabetic patients...

  • What's 'appening with diabetes self-management? Scott, Adrian // Diabetes Digest;2014, Vol. 13 Issue 1, p15 

    The article focuses on the many application software used to help people with diabetes count their calories and carbohydrates, monitor their energy expenditure and adjust their insulin. The need for doctors to conduct robust trials to help them find the most effective technologies for the self...

  • Professional continuous glucose monitoring: Does it improve glycaemic control? Hammond, Peter // Diabetes Digest;2014, Vol. 13 Issue 3, p134 

    The article discusses several studies on new technology for glycaemic control in Type 1 diabetes (T1D). It references published research including one in "Diabetes Technology Therapy" on the use of a professional continuous glucose monitoring (PCGM) device by T1D patients and the use of insulin...

  • Factors Predictive of Use and of Benefit From Continuous Glucose Monitoring in Type 1 Diabetes.  // Diabetes Care;Nov2009, Vol. 32 Issue 11, p1947 

    OBJECTIVE- To evaluate factors associated with successful use of continuous glucose monitoring (CGM) among participants with intensively treated type 1 diabetes in the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Randomized Clinical Trial. RESEARCH DESIGN AND METHODS --...

  • Taking control.  // Good Health (Australia Edition);Apr2010, p84 

    The article discusses various treatment of type 1 and type 2 diabetes. It explains the significance of blood glucose monitoring to diabetics such the development of confidence and understanding of lifestyle choices. It cites the use of insulin in the treatment of type 1 diabetes and elaborates...

  • Rapid Improvement in Blood Glucose Control in a Patient With Type 1 Diabetes and Complete Blindness Using a Continuous Glucose Monitor. Chamberlain, James J.; Gilgen, Emily // Clinical Diabetes;Fall2014, Vol. 32 Issue 4, p186 

    The article describes the case study of a 73-year-old woman suffering from type 1 diabetes with diabetic retinopathy which resulted in bilateral enucleation of the eyes and ocular prostheses. The patient was placed on the Dexcom Seven Plus continuous glucose monitoring (CGM) system that gives...

  • Assessing glycaemic control: self-monitoring of blood glucose. Meetoo, Danny D.; McAllister, Gillian; West, Adele // British Journal of Nursing;8/11/2011, Vol. 20 Issue 15, p919 

    Diabetes Mellitus is a chronic, lifelong metabolic disorder characterized by an elevated blood glucose level resulting from an absolute or relative shortage of insulin. Self-monitoring of blood glucose (SMBG) has escalated over the years following the outcomes of evidence demonstrating a strong...

  • SELF-MONITORED BLOOD GLUCOSE LEVEL TIMING TO REPRESENT HEMOGLOBIN A1C LEVEL IN TYPE 2 DIABETIC PATIENTS. Sutathip Pichayapaiboon; Duangchit Panomvana // International Journal of Pharmacy;2013, Vol. 3 Issue 2, p296 

    Glycosylated hemoglobin A1C (HbA1C) is used to assess treatment efficacy in type 2 diabetic patients (T2DM). It is a function of both fasting and postprandial hyperglycemia. This study evaluated the relationship between different time point of self-monitored blood glucose (SMBG) testing and...

  • Insulin infusion systems, diabetic control, and microvascular complications. Watkins, P.J. // British Medical Journal;2/9/1980, Vol. 280 Issue 6211, p350 

    Focuses on the creation of methods for treatment of diabetes due to complications of insulin infusion systems complications. Application of self-measurement of blood glucose technique; Measurement of glycosylated hemoglobin concentration; Effectiveness of the techniques in avoiding hypoglycemia.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics